Clinical Trials Directory

Trials / Conditions / Stage II Colon Cancer

Stage II Colon Cancer

14 registered clinical trials studyying Stage II Colon Cancer — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
NCT02448173
Vaccinogen IncPhase 3
RecruitingPhase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
NCT05870800
Baylor College of MedicinePhase 2
SuspendedExploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients
NCT05062889
Gruppo Oncologico del Nord-OvestPhase 2
CompletedDasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Ca
NCT04164069
Anne NoonanPhase 1
UnknownAdjuvant Chemotherapy in High Risk Stage II Colon Cancer
NCT04303429
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePhase 3
Active Not RecruitingOxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer
NCT04416490
Boryung Pharmaceutical Co., Ltd—
UnknownReal-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After R
NCT03958435
Second Affiliated Hospital, School of Medicine, Zhejiang University—
CompletedExercise and Colon Cancer
NCT02250053
Abramson Cancer Center at Penn MedicineN/A
CompletedLow Glycemic Load Diet in Patients With Stage I-III Colon Cancer
NCT02129218
Case Comprehensive Cancer CenterN/A
UnknownA Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer
NCT02887365
National Taiwan University HospitalPhase 4
TerminatedPolyphenon E in Treating Patients With High-Risk of Colorectal Cancer
NCT01606124
Mayo ClinicPhase 2
CompletedResveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
NCT00433576
National Cancer Institute (NCI)Phase 1
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
CompletedFluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon
NCT00004931
National Cancer Institute (NCI)Phase 3